For the third consecutive month, the markets closed in positive territory, as the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 4.1%, 5.3% and 3.3%, respectively. Despite the major US stock indexes trading within a narrow range for most of May, investors turned bullish during the final two trading days of the month due […]
The crystal ball is very cloudy, according to the results of IBO’s Spring 2009 Business Climate Survey. Twice a year, IBO surveys executives at analytical and life science instrument and laboratory product companies to gage their expectations for business conditions in the short term, and to gain their opinions on current issues affecting the market. […]
In fiscal 2008, average short-term and long-term compensation for 56 executives at 44 analytical instrument and laboratory product companies in IBO’s three Stock Indexes (see IBO 4/30/09) increased, according to the latest results of IBO’s annual Executive Compensation Survey. Average total short-term compensation grew 5.1% to $1,199,310, while average total long-term compensation rose 13.2% to […]
First-quarter revenues for IBO’s Laboratory Instrument Sales Index declined 2.4% to $4,863 million. Operating profit improved 2.0% to $849 million, and operating margin climbed 80 basis points to 17.5% of sales. Revenues were adversely affected by the economic slowdown and, for US firms, by the higher valuation of the US dollar. A majority of companies […]
Columbus, OH 4/30/09—Mettler-Toledo has announced an expansion of its $40 million cost savings program that began in the fourth quarter of 2008 in response to the economic downturn. The program will now aim for $100 million in annual savings, including a $50 million reduction in personnel costs. In total, the company plans to reduce its […]
The IBO Laboratory Sales Index has been updated from the February 15 issue now that 19 of the 21 companies in the Index have reported calendar-year 2008 results. Estimates are provided for Oxford Instruments and Shimadzu. For the fourth quarter, Laboratory Sales Index revenues improved 1.1% to $4,715 million. Operating profits grew 2.4%, and operating […]
In April, all major US stock indexes climbed higher despite weak economic data and mixed first-quarter earnings. The Dow Jones Industrial Average, S&P 500 and NASDAQ finished the month up 7.3%, 9.4% and 12.3%, respectively. The markets shrugged off higher than expected unemployment claims, increasing foreclosure rates and the report of a 6.1% annual decline […]
As federal agencies begin to receive American Recovery and Reinvestment Act (ARRA) funds (see IBO 2/28/09)—the so-called US stimulus funding—they are releasing more information about how they plan to spend the money. Of all of the agencies, the NIH was the largest beneficiary (see IBO 2/28/09) of ARRA funds for research. This article will outline […]
Fourth-quarter sales for the Lab Equipment/Consumables Sales Index declined 1.2% to $866.20 million, while operating profits improved 5.6% to $265.08 million. Operating margins rose 200 basis points to 30.6% of sales due to cost savings initiatives by a majority of companies in the Index. For the year, Index sales improved 7.5% to $3,557.89 million, operating […]
On March 11, the US Omnibus Appropriations Act of 2009 became law, funding 12 federal agencies for which Congress had not passed a budget for the fiscal year that started on October 1, 2008. Since last fall, these agencies had been funded under a continuing extension (see IBO 10/15/08). According to the American Association for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
